Apellis Pharmaceuticals Inc (APLS)
28.06
-0.19
(-0.67%)
USD |
NASDAQ |
Nov 14, 16:00
28.04
-0.02
(-0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Return Level: 28.06 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 28.06 |
November 13, 2024 | 28.25 |
November 12, 2024 | 29.26 |
November 11, 2024 | 29.58 |
November 08, 2024 | 29.98 |
November 07, 2024 | 28.74 |
November 06, 2024 | 28.83 |
November 05, 2024 | 28.08 |
November 04, 2024 | 28.56 |
November 01, 2024 | 27.98 |
October 31, 2024 | 27.26 |
October 30, 2024 | 27.71 |
October 29, 2024 | 27.41 |
October 28, 2024 | 27.34 |
October 25, 2024 | 26.68 |
October 24, 2024 | 27.58 |
October 23, 2024 | 26.98 |
October 22, 2024 | 27.60 |
October 21, 2024 | 26.88 |
October 18, 2024 | 28.00 |
October 17, 2024 | 27.92 |
October 16, 2024 | 27.95 |
October 15, 2024 | 27.95 |
October 14, 2024 | 27.38 |
October 11, 2024 | 27.14 |
Date | Value |
---|---|
October 10, 2024 | 26.67 |
October 09, 2024 | 26.90 |
October 08, 2024 | 27.40 |
October 07, 2024 | 27.45 |
October 04, 2024 | 27.51 |
October 03, 2024 | 28.06 |
October 02, 2024 | 28.48 |
October 01, 2024 | 27.74 |
September 30, 2024 | 28.84 |
September 27, 2024 | 29.47 |
September 26, 2024 | 29.85 |
September 25, 2024 | 30.59 |
September 24, 2024 | 30.75 |
September 23, 2024 | 32.72 |
September 20, 2024 | 32.51 |
September 19, 2024 | 36.73 |
September 18, 2024 | 35.63 |
September 17, 2024 | 35.53 |
September 16, 2024 | 36.31 |
September 13, 2024 | 37.62 |
September 12, 2024 | 36.78 |
September 11, 2024 | 38.36 |
September 10, 2024 | 39.18 |
September 09, 2024 | 39.94 |
September 06, 2024 | 41.05 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
47.36
Average
45.18
Median
Total Return Level Benchmarks
Biomarin Pharmaceutical Inc | 65.60 |
Ionis Pharmaceuticals Inc | 37.23 |
EyePoint Pharmaceuticals Inc | 10.49 |
Cassava Sciences Inc | 44.19 |
Macrogenics Inc | 3.81 |